Table 3 Management of COVID-19 patients in the clinic [38]
From: Clinical progression of patients with COVID-19 in Lagos State, Nigeria
The period from admission to discharge | All patients (N = 1337) |
|---|---|
Definitions of severe patients | |
Respiratory rate > 35/min | 212 (15.85%) |
Mean oxygen saturation < 93% | 195 (14.58%) |
PaO2/FiO2 ≤ 300 mmHg | 89 (6.65%) |
Lung lesion progression > 50% within 24–48 h | 26 (1.94%) |
Treatment | |
Antiviral therapy | 276 (20.64%) |
Antibiotic therapy | 266 (19.89%) |
Use of corticosteroid | 109 (8.15%) |
Oxygen support | |
Nasal catheter | 186 (13.91%) |
Mask oxygen | 89 (6.65%) |
High-flow nasal cannula | 116 (8.67%) |
Assisting ventilation | |
Bipap | 49 (3.66%) |
Invasive mechanical ventilation | 15 (1.12%) |
Outcome | |
Discharge | 188 (14.06%) |
Continue to be hospitalized | 38 (2.84%) |
ICU | 19 (1.42%) |
Death | 29 (2.16%) |